The Engine has returned once more to back a $30m round for Kytopen, having first invested in the MIT spinout in 2017.
Kytopen, a US-based engineered cell therapies technology spinout of Massachusetts Institute of Technology (MIT), picked up $30m in a series A round featuring Harvard University and MIT-backed incubator and venture fund The Engine.
Northpond Ventures led the oversubscribed round, which additionally attracted Horizons Ventures, Mass Ventures and Alexandria Venture Investments, a unit of life sciences real estate investment trust Alexandria Real Estate Equities, as well as private investors Michael Chambers and John Ballantyne.
Founded in 2017, Kytopen is working on…
